Day: May 4, 2023

UPDATE — Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update

Written by Customer Service on May 4, 2023. Posted in Earnings Releases And Operating Results.

FLORHAM PARK, N.J., May 04, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update. First Quarter and Recent Corporate HighlightsPresented at both the Roth Capital Partners 35th Annual Conference on March 13, 2023, and the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023. A replay of the Oppenheimer presentation is available on the Events Page of the Company’s IR website.“We maintained strong operational momentum in the first quarter, with our primary focus being the execution of our pivotal trial of iopofosine in Waldenstrom’s macroblobulinemia (WM). In parallel...

AMG Announces Final 2022 Dividend

Written by Customer Service on May 4, 2023. Posted in Dividend Reports And Estimates.

Amsterdam, 4 May 2023 (Regulated Information) — AMG Advanced Metallurgical Group N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) is pleased to announce that during the Annual General Meeting, held on May 4, 2023, AMG’s shareholders approved the payment of a dividend of €0.70 per ordinary share over the financial year 2022. The interim dividend of €0.30, paid on August 10, 2022, was deducted from the amount distributed to shareholders. The final dividend per ordinary share therefore amounts to €0.40. Payment of the final dividend will be completed on or around May 11, 2023, to shareholders of record on May 9, 2023. The ex-dividend date is May 8, 2023. Dutch withholding tax will be deducted from the dividend at a rate of 15%. This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. This...

Tejon Ranch Co. Announces First Quarter 2023 Financial Results

Written by Customer Service on May 4, 2023. Posted in Earnings Releases And Operating Results.

TEJON RANCH, Calif., May 04, 2023 (GLOBE NEWSWIRE) — Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results for the three-months ended March 31, 2023. “Activity at the Tejon Ranch Commerce Center (TRCC) remains strong. Most recently, in conjunction with our joint venture partner Majestic Realty, we have started construction on a new 446,000 square foot industrial building that was pre-leased to Sunrise Brands, a leading apparel company. We expect our new tenant to take occupancy in early 2024,” said Gregory S. Bielli, President and CEO of Tejon Ranch Co.” This building is part of the nearly 2.0 million square feet of space either under construction, recently completed, or about to begin construction in the next 12 months in...

CPP Announces Acquisition of Allegheny Commons Apartments in Pittsburgh, Pennsylvania

Written by Customer Service on May 4, 2023. Posted in Mergers And Acquisitions.

Planned renovation of 136-unit complex marks CPP’s first investment in PittsburghAllegheny Commons Allegheny CommonsPITTSBURGH, May 04, 2023 (GLOBE NEWSWIRE) — CPP (Community Preservation Partners), a mission-driven affordable housing preservation developer, today announced the closing of Allegheny Commons apartments. The community is located at 255 E. Ohio Street, in the revitalized and highly desirable North Shore neighborhood of Pittsburgh. The 136-unit multifamily complex is less than a mile from the Central Business District and marks the first investment in this market for CPP. CPP’s total development investment is expected to be approximately $46.4 million, with a total investment in renovations of $11.3 million. Renovation begins immediately and is expected to be completed by February 2024. Throughout the renovation...

Form 8.3 – Sureserve Group plc

Written by Customer Service on May 4, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Sureserve Group plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing...

Landsbankinn hf.: Financial results of Landsbankinn for the first three months of 2023

Written by Customer Service on May 4, 2023. Posted in Earnings Releases And Operating Results.

Return on equity (ROE) at Landsbankinn was 11.1% in the first three months of 2023. Net profit was ISK 7.8 billion. On-going development of services and sound operation for the past several years result in continued decline of the ratio of operating expenses to average total assets, currently 1.4%. Net interest income grew by 27.3% compared to the same period in 2022. The net interest margin is 2.8%, up by 0.4 percentage points from the same period in 2022. Increased interest income is mainly from a growing loan book and improved returns on the Bank’s liquidity portfolio. Rising interest rate levels also contribute to growing interest income, yet interest expense has also grown. Net fee and commission income grew by 15.5% between years, reflecting good breadth in the Bank’s service platform. The cost/income ratio was 33.3%, with costs...

Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update

Written by Customer Service on May 4, 2023. Posted in Earnings Releases And Operating Results.

Cohen & Company Reports First Quarter 2023 Financial Results

Written by Customer Service on May 4, 2023. Posted in Dividend Reports And Estimates.

Board Declares Quarterly Dividend of $0.25 per Share PHILADELPHIA and NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN), a financial services firm specializing in an expanding range of capital markets and asset management services, today reported financial results for its first quarter ended March 31, 2023. Summary Operating Results Three Months Ended($ in thousands) 3/31/23 12/31/22 3/31/22 Net trading $ 8,210 $ 9,644 $ 12,022 Asset management 2,025 1,761 1,889 New issue and advisory 900 4,235 3,770 Principal transactions and other revenue (2,311 ) (3,190 ) (18,363 )Total revenues 8,824 12,450 (682 )Compensation and benefits 10,537 8,970 13,879 Non-compensation...

InterDigital Announces Financial Results for First Quarter 2023

Written by Customer Service on May 4, 2023. Posted in Earnings Releases And Operating Results.

Samsung arbitration agreement and Lenovo judgment drive total revenue to over $200 million; record return of capital to shareholders WILMINGTON, Del., May 04, 2023 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development company, today announced results for the quarter ended March 31, 2023. “In the first quarter, we continued to make strong progress in executing against our long-term goals,” commented Liren Chen, President and CEO, InterDigital. “The recent Lenovo judgment, along with our Samsung arbitration agreement and the 2022 Apple renewal, drove exceptional financial results in first quarter 2023 and provide a strong recurring revenue base well into the future.” First Quarter 2023 Financial Highlights, as compared to First Quarter 2022: GAAPTotal revenue was...

Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update

Written by Customer Service on May 4, 2023. Posted in Earnings Releases And Operating Results.

Initiated patient enrollment in a U.S. Phase 2/3 study of CTX-009 (DLL4 /VEGF-A bispecific antibody) in patients with advanced biliary tract cancers (BTC). Top line data is expected in the first half of 2024 Continue to enroll in a U.S. Phase 2 study of CTX-009 in patients with advanced colorectal cancer (CRC). Initial data expected in the third quarter of 2023 Presented results of a Phase 2 study of CTX-009 in combination with paclitaxel in patients with BTC at the 2023 ASCO GI Cancers Symposium Expanded the management team with the appointment of Minori Rosales, M.D. PhD, as Senior Vice President & Head of Clinical Development Appointed Richard Lindahl, M.B.A., EVP & CFO of Emergent BioSolutions, to the Compass Board Ended the first quarter with $175 million in cash and marketable securities, providing cash runway for the...

Day: May 4, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice